← Leaderboards
Michael V Autieri
Temple University
$11,984,546
Attributed
$12,805,575
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2006–24$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,805,575 · 6
By mechanism
R01$12,805,575 · 6
Top collaborators
- Rosario G Scalia3 shared
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineInflammatoryBlood VesselsPathway InteractionsCellsIn VivoInterleukin-19ReportingInflammationFunctional DisorderMolecularSmooth Muscle MyocytesMediatingResponseAtherosclerosisGene ExpressionPhenotypeRegulationVascular DiseasesAnti-Inflammatory AgentsKnock-DownArteriesInjuredCarotid Arteries
Grant awards (31)
Regulation of adipose tissue microvascular function by IL19$532,559
R01 · FY2024 · DK
Regulation of adipose tissue microvascular function by IL19$554,750
R01 · FY2023 · DK
Regulation of adipose tissue microvascular function by IL19$554,750
R01 · FY2022 · DK
miRNA-mediated reduction of VSMC foam cell formation$535,716
R01 · FY2022 · HL · contact PI
miRNA-mediated reduction of VSMC foam cell formation$535,716
R01 · FY2021 · HL · contact PI
Attenuation of atherosclerosis by regulation of VSMC inflammatory gene mRNA stability$491,772
R01 · FY2021 · HL · contact PI
miRNA-mediated reduction of VSMC foam cell formation$535,716
R01 · FY2020 · HL · contact PI
Attenuation of atherosclerosis by regulation of VSMC inflammatory gene mRNA stability$491,772
R01 · FY2020 · HL · contact PI
miRNA-mediated reduction of VSMC foam cell formation$535,716
R01 · FY2019 · HL · contact PI
Attenuation of atherosclerosis by regulation of VSMC inflammatory gene mRNA stability$491,772
R01 · FY2019 · HL · contact PI
Attenuation of atherosclerosis by regulation of VSMC inflammatory gene mRNA stability$491,772
R01 · FY2018 · HL · contact PI
Interleukin-19 Inhibits Atherosclerosis by Diverse Mechanisms$424,028
R01 · FY2016 · HL · contact PI
Mechanisms of Th2 interleukin-driven angiogenesis$390,000
R01 · FY2016 · HL · contact PI
Interleukin-19 Inhibits Atherosclerosis by Diverse Mechanisms$417,668
R01 · FY2015 · HL · contact PI
Mechanisms of Th2 interleukin-driven angiogenesis$384,150
R01 · FY2015 · HL · contact PI
Interleukin-19 Inhibits Atherosclerosis by Diverse Mechanisms$415,548
R01 · FY2014 · HL · contact PI
Mechanisms of Th2 interleukin-driven angiogenesis$381,792
R01 · FY2014 · HL · contact PI
Interleukin-19 Inhibits Atherosclerosis by Diverse Mechanisms$401,089
R01 · FY2013 · HL · contact PI
Mechanisms of Th2 interleukin-driven angiogenesis$368,900
R01 · FY2013 · HL · contact PI
Suppression of VSMC Activation and Mechanisms of Vascular Protection by IL-19$371,250
R01 · FY2012 · HL · contact PI
Suppression of VSMC Activation and Mechanisms of Vascular Protection by IL-19$375,000
R01 · FY2011 · HL · contact PI
Suppression of VSMC Activation and Mechanisms of Vascular Protection by IL-19$375,000
R01 · FY2010 · HL · contact PI
Suppression of VSMC Activation and Mechanisms of Vascular Protection by IL-19$375,000
R01 · FY2009 · HL · contact PI
AIF-1 Expression in VSMC Growth and Arteriopathy$327,713
R01 · FY2009 · HL · contact PI
AIF-1 Expression in VSMC Growth and Arteriopathy$327,713
R01 · FY2008 · HL · contact PI
AIF-1 Expression in VSMC Growth and Arteriopathy$327,713
R01 · FY2007 · HL · contact PI
AIF-1 Expression in V SMC Growth and Arteriopathy$337,500
R01 · FY2006 · HL · contact PI
AIF-1 Expression In VSMC Growth And Arteriopathy$263,375
R01 · FY2004 · HL
AIF-1 Expression In VSMC Growth And Arteriopathy$263,375
R01 · FY2003 · HL
AIF-1 Expression In VSMC Growth And Arteriopathy$263,375
R01 · FY2002 · HL
AIF-1 Expression In VSMC Growth And Arteriopathy$263,375
R01 · FY2001 · HL